SMTL ID : 6ilq.1

Crystal structure of PPARgamma with compound BR101549

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.41 Å

Oligo State

hetero-1-1-mer

Ligands

1 x AE0: ethyl [2-butyl-6-oxo-1-{[2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)[1,1'-biphenyl]-4-yl]methyl}-4-(propan-2-yl)-1,6-dihydropyrimidin-5-yl]acetate(Non-covalent)

AE0.1: 19 residues within 4Å: Chain A: F.21, L.23, I.76, G.79, C.80, R.83, S.84, A.87, I.121, M.124, L.128, V.134, I.136, S.137, E.138, M.143, L.148, M.159, H.244 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.21, A:I.76, A:I.121, A:I.121, A:M.124, A:V.134, A:I.136, A:L.148 Hydrogen bonds: A:R.83, A:R.83, A:E.138

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Choung, W. et al., Identification of BR101549 as a lead candidate of non-TZD PPAR gamma agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR. Bioorg.Med.Chem.Lett. (2019)

Release Date

2019-09-11

Peptides

Peroxisome proliferator-activated receptor gamma: A
Nuclear receptor coactivator 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Peroxisome proliferator-activated receptor gamma

Nuclear receptor coactivator 1

Related Entries With Identical Sequence